Form D · Other
Aegle Health Partners, Inc.
Minneapolis, MN · CIK 0001896471
Offering snapshot reported Aug 21, 2026 · SEC filing
- Reported sold
- $2.4M Offering amount: $7M
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $12.5K Reported outside-investor minimum
- First sale
- Aug 4, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 21, 2026 | Initial | $2,395,000 | No comparison | 10 | SEC filing |
| Dec 2, 2021 | Initial | $500,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-595062
Source: Form D, filed Aug 21, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Timothy Nmn Lee | Director, Executive |
| Kyle Rolfing | Executive |
| Gerardo Pietro Zampaglione | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
4999 France Ave S Suite 255
Minneapolis, MN, 55410
Minneapolis, MN, 55410